We're in beta. Stay tuned for updates.x
Loading...
PODCAST

On The Pen With Dave Knapp

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

All Episodes

00:42:22
GLP-1 Microdosing For Weight Loss: Noom CEO Explains...
en-us
00:59:23
Eli Lilly Earnings Call Recap: Stock Tanks on Weight...
en-us
00:24:38
Novo Nordisk Blames Compound Semaglutide on Slower Sales
en-us
00:41:14
No Compounded Retatrutide Says the FDA + Tons of...
en-us
00:26:46
LEAKED TRUMP DOCUMENT: Medicare to Cover Zepbound and...
en-us
00:33:17
Retatrutide Drops are Crazy // OTP TWD 7.29.25
en-us
00:24:04
Compound GLP-1 Injections : You Won't Believe What...
en-us
00:26:22
Connecticut Making Ozempic!? Meet The Mastermind
en-us
00:20:20
SHOCKING: How GLP-1 Protects the Heart Beyond Weight...
en-us
00:17:34
BREAKING: Insurance Approving Mounjaro Over...
en-us
00:35:23
Behind the Scenes of the Obesity Drug Battle |...
en-us
00:33:37
Unlocking Zepbound Insurance Coverage + More GLP-1...
en-us
00:26:52
Lilly Could Lose Their Tirzepatide Patent! Plus ADA...
en-us
00:57:43
Faces of The Fight: The Jamie Selzler Story
en-us
00:29:32
Zepbound Vials Drop, Amycretin Surges, FDA Fast...
en-us
00:22:33
GLP-1 Access Progress + The Race for Less Frequent...
en-us
00:21:18
Lilly Makes Bold Move on GLP Dosing / 8x More...
en-us
00:29:47
Trump Admin Setting Price Targets for Zepbound and...
en-us
00:41:02
Zepbound vs. Wegovy, CVS vs. Patients, and the...
en-us
00:26:31
Compound Tirzepatide Lawsuit + PBM Reform Update //...
en-us
156 results

Similar Podcasts